TheraMind Overview

  • Founded
  • 2007


  • Status
  • Out of Business

  • Latest Deal Type
  • Out of Business

TheraMind General Information


Operator of a biopharmaceutical company intended to develop anti-epileptic compounds. The company's biopharmaceutical includes biologics for biomedical research and therapeutics by utilizing multi-disciplinary approach and cutting-edge neuroscience technologies to investigate neurobiological mechanisms underlying a variety of nervous system illnesses, enabling neuropsychiatric disorder patients to avail genetic therapeutics to multiple nervous system diseases.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly Accelerator/Incubator backed
Primary Industry
Drug Discovery
Other Industries
Primary Office
  • 6614 Clayton Road
  • Suite 133
  • Clayton, MO 63117
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

TheraMind Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Out of Business 01-Nov-2011 Completed Out of Business
2. Accelerator/Incubator 01-Jan-2011 Completed Startup
1. Accelerator/Incubator Completed Startup
To view TheraMind’s complete valuation and funding history, request access »